Bio-Techne (TECH) Interest Expenses (2014 - 2026)
Bio-Techne (TECH) recorded quarterly Interest Expenses of $2.4 million in Q1 2026, up 10.64% quarter-over-quarter from $2.2 million in Q4 2025, and up 19.68% on a YoY basis from $2.0 million in Q1 2025.
Bio-Techne (TECH) Interest Expenses (2014 - 2026) Analysis & Trends
Bio-Techne's Interest Expenses history runs 13 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 19.68% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.7 million (up 9.56% YoY), while the FY2025 annual figure was $8.5 million, down 45.93% from the prior year.
- Interest Expenses was $2.4 million for Q1 2026 at Bio-Techne, up from $2.2 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $4.9 million in Q3 2023 to a low of $1.4 million in Q1 2023.
- Historically, Interest Expenses has averaged $2.8 million across 5 years, with a median of $2.5 million in 2022.
- Biggest YoY gain for Interest Expenses was 192.98% in 2024; the steepest drop was 55.53% in 2024.
- A 5-year view of Interest Expenses shows it stood at $2.4 million in 2022, then soared by 83.74% to $4.3 million in 2023, then sank by 50.38% to $2.1 million in 2024, then increased by 1.07% to $2.2 million in 2025, then rose by 10.64% to $2.4 million in 2026.
- The last three Interest Expenses figures came in at $2.4 million (Q1 2026), $2.2 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |